Leadership Overview
Alkem has 10 executives leading key functions including strategy, finance, information technology, research and development, and sales.
Driven by a commitment to global health, Alkem is dedicated to developing, manufacturing, and distributing high-quality pharmaceutical and nutraceutical products, impacting patient well-being worldwide.
Driven by a commitment to global health, Alkem is dedicated to developing, manufacturing, and distributing high-quality pharmaceutical and nutraceutical products, impacting patient well-being worldwide.
Leadership Roles at Alkem
Ravindra Sharma - Chief Executive Officer
Ravindra Sharma, the Chief Executive Officer at Alkem, directs the company's overall strategic vision and operational execution. Sharma guides the organization's expansion into new global markets, ensuring alignment with Alkem's mission to provide accessible pharmaceutical solutions. This leadership role involves overseeing all major business units and fostering a culture of innovation across research, development, and manufacturing. Sharma's strategic direction is crucial for navigating the complex regulatory landscapes and competitive dynamics inherent in the global pharmaceutical industry. By championing operational excellence, Ravindra Sharma drives the company's sustained growth and reinforces Alkem's position as a leading Indian pharmaceutical entity with significant international reach. The Chief Executive Officer's purview encompasses long-term planning and resource allocation to support Alkem's ongoing commitment to improving global health outcomes through its diverse product portfolio.
Yugandhara Hiray - Manager - Strategy and CEO's Chief of Staff
Yugandhara Hiray, the Manager - Strategy and CEO's Chief of Staff at Alkem, provides critical support to the Chief Executive Officer in shaping and executing strategic initiatives. Hiray is instrumental in coordinating cross-functional teams, facilitating communication between departments, and ensuring the efficient implementation of Alkem's strategic objectives. This role is pivotal in translating the CEO's vision into actionable plans that drive Alkem's global operations and product development. Yugandhara Hiray's involvement in strategic planning ensures that Alkem's efforts in developing, manufacturing, and selling pharmaceutical and nutraceutical products are aligned with market demands and corporate goals. By managing key strategic projects and acting as a liaison, Hiray contributes significantly to Alkem's sustained growth and its mission to enhance global health outcomes.
Rajesh Dubey - Chief Financial Officer
Rajesh Dubey, the Chief Financial Officer at Alkem, manages the company's financial health and strategic fiscal planning. Dubey oversees all financial operations, including accounting, treasury, and investor relations, ensuring robust financial controls and compliance with international standards. This executive function is critical for supporting Alkem's global manufacturing and distribution network, enabling efficient resource allocation for product development and market penetration. Rajesh Dubey's expertise guides investment decisions, capital management, and risk mitigation strategies, directly contributing to the company's profitability and long-term financial stability. By optimizing financial performance, Dubey ensures Alkem can continue its mission of delivering essential pharmaceutical and nutraceutical products worldwide. The Chief Financial Officer's responsibilities extend to forecasting financial needs for R&D initiatives and international market expansion, solidifying Alkem's economic resilience.
Dishant Doshi - Vice President, Finance & Head Chief Financial Officer, S Office
Dishant Doshi, the Vice President, Finance & Head Chief Financial Officer, S Office at Alkem, supports the Chief Financial Officer in managing the company's financial operations and strategic fiscal planning. Doshi oversees critical financial functions, ensuring adherence to regulatory requirements and optimizing financial performance across Alkem's global business units. This executive position is vital for maintaining the financial integrity of Alkem's extensive manufacturing and distribution network. Dishant Doshi's contributions are essential for supporting Alkem's ongoing investment in research and development and its expansion into international markets. By ensuring efficient financial management and robust internal controls, Doshi reinforces Alkem's capacity to deliver high-quality pharmaceutical and nutraceutical products worldwide and sustain its growth trajectory.
Ashish Sehgal - President, Research Development, Regulatory Affairs & International Portfolio
Ashish Sehgal, the President, Research Development, Regulatory Affairs & International Portfolio at Alkem, leads the company's innovation pipeline and global market access strategies. Sehgal directs all aspects of research and development, ensuring the creation of novel pharmaceutical and nutraceutical products that meet evolving healthcare needs. This leadership role is crucial for navigating complex international regulatory environments and securing approvals for Alkem's diverse product offerings across various global markets. Ashish Sehgal's oversight of the international portfolio drives market penetration and revenue growth in key regions. By championing scientific advancement and strategic regulatory compliance, Sehgal ensures Alkem's continued ability to deliver life-enhancing medicines and health products worldwide.
Sunil Pathak - President, Semi Chronic Business, Oncology, Biosimilar
Sunil Pathak, the President, Semi Chronic Business, Oncology, Biosimilar at Alkem, drives the strategic growth and market presence for critical therapeutic areas. Pathak oversees the development, marketing, and sales of Alkem's specialized product lines, including treatments for semi-chronic conditions, oncology, and biosimilars. This executive function is paramount in ensuring that patients have access to advanced and affordable healthcare solutions. Sunil Pathak's leadership focuses on expanding Alkem's footprint in these vital segments, both domestically and internationally. By managing these key business units, Pathak contributes significantly to Alkem's mission of improving patient outcomes and strengthening its position as a comprehensive pharmaceutical provider globally.
Shirish Ambulgekar - President
Shirish Ambulgekar, the President at Alkem, directs significant operational functions that underpin the company's manufacturing and supply chain excellence. Ambulgekar is responsible for optimizing production processes, ensuring quality control across all manufacturing sites, and managing the efficient distribution of Alkem's pharmaceutical and nutraceutical products. This leadership role is critical for maintaining Alkem's capacity to meet global demand and uphold its commitment to delivering high-quality medicines. Shirish Ambulgekar's focus on operational efficiency and supply chain integrity directly supports Alkem's mission to provide accessible healthcare solutions worldwide. By overseeing these core operational areas, Ambulgekar ensures the reliable availability of Alkem's extensive product portfolio to patients across diverse international markets.
Mukesh Tiwary - President, Marketing & Sales
Mukesh Tiwary, the President, Marketing & Sales at Alkem, spearheads the company's commercial strategies and market expansion initiatives. Tiwary directs all marketing and sales efforts, driving revenue growth and enhancing Alkem's brand presence across its global markets. This executive role is crucial for connecting Alkem's innovative pharmaceutical and nutraceutical products with healthcare providers and patients worldwide. Mukesh Tiwary's leadership ensures effective market penetration and customer engagement, translating Alkem's research and development successes into tangible commercial outcomes. By optimizing sales channels and marketing campaigns, Tiwary plays a vital part in achieving Alkem's mission of improving global health and accessibility to essential medicines.
Ramanarayana Parhi - Vice President & Chief Information Officer
Ramanarayana Parhi, the Vice President & Chief Information Officer at Alkem, architects the company's technology infrastructure and digital transformation initiatives. Parhi directs the implementation of advanced IT systems that support Alkem's global operations, from research and development to manufacturing and sales. This leadership position is vital for enhancing operational efficiency, data security, and seamless communication across Alkem's international presence. Ramanarayana Parhi's strategic vision for technology ensures that Alkem remains at the forefront of digital innovation within the pharmaceutical sector. By leveraging cutting-edge solutions, the Vice President & Chief Information Officer drives improvements in supply chain management and customer engagement. Parhi's oversight of information systems is fundamental to Alkem's ability to develop, manufacture, and distribute pharmaceutical products effectively on a global scale.

Chandra Uppu - Product Manager, Digital & Chief Information Officer, Corporate Strategy ( Office)
Chandra Uppu, the Product Manager, Digital & Chief Information Officer, Corporate Strategy ( Office) at Alkem, spearheads digital product development and strategic information technology integration. Uppu focuses on enhancing Alkem's digital presence and leveraging technology to drive corporate strategy, particularly within the digital product landscape. This role is essential for identifying and implementing innovative digital solutions that support Alkem's mission of delivering pharmaceutical and nutraceutical products globally. Chandra Uppu's responsibilities include overseeing the strategic alignment of IT resources with business objectives, ensuring that digital initiatives contribute directly to market growth and operational effectiveness. By managing digital product portfolios and IT strategy, Uppu plays a key part in Alkem's ongoing evolution and its commitment to accessible healthcare solutions worldwide.
Explore Leadership Teams in Manufacturing
Baxter International is a global healthcare company that develops and manufactures medical devices, pharmaceuticals, and hospital care products. Its offerings include infusion systems, injectable therapies, surgical technologies, and patient monitoring solutions used by hospitals, clinics, and healthcare providers worldwide.
Company Leadership SW

OS

Teva Pharmaceutical Industries Ltd. is a global biopharmaceutical leader focused on improving health outcomes for patients worldwide. Enabled by a world-class generics business, Teva develops, manufactures, and delivers a broad portfolio of medicines, including complex generics, biosimilars, innovative therapies, and pharmacy brands. The company is dedicated to addressing unmet patient needs by advancing scientific research, expanding access to quality medicines, and streamlining the delivery of treatments -from established generics to cutting-edge therapeutic solutions.
Company Leadership EB
YK
CS
AL
Founded in 1668 and headquartered in Darmstadt, Germany, Merck KGaA is a multinational pharmaceutical, chemical and life sciences company. Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Tokyo and Beijing.
Company Leadership BZ
LB
AB
Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (API's), intermediates, and formulations in India, the United States, Europe, and internationally. It offers oncology and non-oncology API's.; and new drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company also provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. It is also involved in the wind power generation activities. Shilpa Medicare Limited was incorporated in 1987 and is headquartered in Raichur, India.
Company Leadership HB
PJ
HB